查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1689639

局部止血剂市场：全球产业分析、市场规模、份额、成长、趋势与未来预测（2025-2032）

Topical Hemostat Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球局部止血剂市场的综合报告。该报告对市场驱动因素、趋势、机会、驱动因素和挑战等关键市场动态进行了全面评估，并对市场结构提供了详细的见解。本研究报告采用独家资料和统计数据，概述了 2025 年至 2032 年全球局部止血剂市场的预期成长轨迹。

关键见解

  • 局部止血剂市场规模（2025年）：61亿美元
  • 市场规模预测（以金额为准，2032年）：113.6亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：9.3%

局部止血剂市场：分析范围

局部止血剂在外科手术和创伤护理中发挥重要作用，有助于在医疗过程中快速控制出血。这些止血剂广泛应用于医院、门诊手术中心和专科诊所，为小型到大型手术提供有效的解决方案。该市场包括多种局部止血剂，包括可吸收明胶海绵、氧化再生纤维素、基于胶原蛋白的止血剂和基于凝血酶的产品。微创手术的采用率上升、全球手术数量的增加以及止血技术的进步是推动市场成长的主要因素。

市场成长动力：

全球局部止血剂市场受到外科手术数量的增加、需要频繁医疗干预的老龄化人口以及心血管疾病和癌症等慢性疾病患病率上升的推动。此外，微创和机器人辅助手术的日益普及也推动了对有效止血解决方案的需求。技术进步，例如开发具有更好生物相容性和更快作用特性的先进止血剂，也在推动市场扩张。此外，医疗保健专业人士越来越意识到局部止血剂优于传统缝合方法，这也促进了市场扩张。

市场限制：

儘管市场成长潜力很大，但局部止血剂市场面临严格的监管核准、产品成本上升以及某些地区报销有限等挑战。管理止血产品开发和商业化的严格法律规范给製造商带来了合规挑战。此外，先进的止血剂相对昂贵，这可能会阻碍其在成本敏感的市场（尤其是新兴经济体）中的应用。一些医疗保健系统对某些局部止血剂的报销有限，进一步限制了市场渗透。

市场机会：

由于产品不断创新、在各个外科专业的应用范围不断扩大以及在门诊医疗环境中的应用日益广泛，局部止血剂市场提供了巨大的成长机会。生物分解性和生物活性止血剂与基于奈米技术的解决方案的结合有望提高产品的有效性并扩大市场范围。重症监护和军事医疗应用对照护现场止血解决方案的需求不断增长也将为市场扩张开闢新的途径。策略合作、研发投资以及开发具成本效益的止血解决方案将是利用新市场机会的关键。

本报告回答的关键问题

  • 推动全球局部止血剂市场成长的关键因素有哪些？
  • 医疗保健场景中采用最广泛的产品类型和应用有哪些？
  • 技术进步如何影响局部止血剂市场的竞争格局？
  • 谁是塑造市场的关键参与者？他们采取什么策略来维持成长？
  • 全球局部止血剂市场有哪些新兴趋势与前景？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 价值链分析
  • 宏观经济因素
    • 世界GDP展望
    • 全球各地区纺织品种类
    • 全球服饰需求（按地区）
    • 全球针织机销售概况
  • 预测因子－相关性和影响力
  • COVID-19影响评估
  • PESTLE分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 监管和技术格局

第三章 市场动态

  • 驱动程式
  • 限制因素
  • 机会
  • 趋势

第四章 价格趋势分析（2019-2032）

  • 区域价格分析
  • 按细分市场定价
  • 价格影响因素

5. 全球局部止血剂市场展望

  • 主要亮点
  • 全球局部止血剂市场展望（按类型）
    • 简介/主要发现
    • 按类型分類的历史市场规模分析（价值（十亿美元）和数量，2019-2024 年）
    • 当前市场规模分析及按类型预测（价值（十亿美元）和数量，2025-2032）
      • 纤维蛋白
      • 凝血酶
      • 纤维素
      • 胶原蛋白
      • 明胶
      • 胶水
    • 市场吸引力分析：按类型
  • 全球局部止血剂市场应用展望
    • 简介/主要发现
    • 按应用分類的历史市场规模分析（价值（十亿美元）和数量，2019-2024 年）
    • 目前市场规模分析及应用预测（价值（十亿美元）和数量，2025-2032）
      • 一般外科
      • 神经外科
      • 血管外科
      • 心血管外科
    • 市场吸引力分析：按应用
  • 全球局部止血剂市场展望（依最终用途）
    • 简介/主要发现
    • 按最终用途分類的历史市场规模分析（价值（十亿美元）和数量，2019-2024 年）
    • 目前市场规模分析及依最终用途预测（价值（十亿美元）及数量，2025-2032）
      • 医院
      • 门诊手术中心

6. 全球局部止血剂市场（按地区）展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（价值（十亿美元）和数量，2019-2024 年）
  • 目前市场规模分析及各地区预测（价值（十亿美元）及数量，2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

7. 北美局部止血剂市场展望

8. 欧洲局部止血剂市场展望

9. 东亚局部止血剂市场展望

10. 南亚和大洋洲局部止血剂市场展望

第 11 章拉丁美洲局部止血剂市场展望

12.中东和非洲局部止血剂市场展望

第十三章竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞赛实力图谱
    • 竞争仪錶板
  • 公司简介
    • BD
    • Baxter
    • Pfizer Inc.
    • Medicom
    • HemoSonics
    • Hemostasis, LLC
    • Medline Industries
    • Johnson &Johnson
    • Integra LifeSciences
    • Teleflex Incorporated
    • HemCon Medical Technologies Inc.

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35166

Persistence Market Research has recently released a comprehensive report on the worldwide market for topical hemostats. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global topical hemostat market from 2025 to 2032.

Key Insights:

  • Topical Hemostat Market Size (2025E): US$ 6.10 Bn
  • Projected Market Value (2032F): US$ 11.36 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Topical Hemostat Market - Report Scope:

Topical hemostats play a crucial role in surgical and trauma care, aiding in the rapid control of bleeding during medical procedures. These hemostatic agents are widely used in hospitals, ambulatory surgical centers, and specialty clinics, providing effective solutions for both minor and major surgical interventions. The market encompasses a diverse range of topical hemostats, including absorbable gelatin sponges, oxidized regenerated cellulose, collagen-based hemostats, and thrombin-based products. The growing adoption of minimally invasive surgeries, an increasing number of surgical procedures worldwide, and advancements in hemostatic technologies are key factors propelling market growth.

Market Growth Drivers:

The global topical hemostat market is driven by the rising number of surgical procedures, an aging population requiring frequent medical interventions, and the increasing prevalence of chronic conditions such as cardiovascular diseases and cancer. The demand for effective bleeding control solutions is also bolstered by the growing adoption of minimally invasive and robotic-assisted surgeries. Technological advancements, such as the development of advanced hemostatic agents with enhanced biocompatibility and rapid action, further support market expansion. Additionally, increased awareness among healthcare professionals about the benefits of topical hemostats over traditional suturing methods contributes to market growth.

Market Restraints:

Despite strong growth potential, the topical hemostat market faces challenges related to stringent regulatory approvals, high product costs, and reimbursement limitations in certain regions. Stringent regulatory frameworks governing the development and commercialization of hemostatic products pose compliance challenges for manufacturers. Additionally, the relatively high cost of advanced hemostatic agents may hinder their adoption in cost-sensitive markets, particularly in emerging economies. Limited reimbursement coverage for certain topical hemostats in some healthcare systems further restricts market penetration.

Market Opportunities:

The topical hemostat market presents significant growth opportunities driven by continuous product innovation, expanding applications in various surgical specialties, and increasing adoption in ambulatory care settings. The integration of biodegradable and bioactive hemostats, along with nanotechnology-based solutions, is expected to enhance product effectiveness and expand market scope. The rising demand for point-of-care hemostatic solutions in emergency and military medical applications also creates new avenues for market expansion. Strategic collaborations, investments in R&D, and the development of cost-effective hemostatic solutions will be key to capitalizing on emerging market opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the topical hemostat market globally?
  • Which product types and applications are witnessing the highest adoption across different healthcare settings?
  • How are technological advancements influencing the competitive landscape of the topical hemostat market?
  • Who are the key players shaping the market, and what strategies are they employing to sustain growth?
  • What are the emerging trends and future prospects in the global topical hemostat market?

Competitive Intelligence and Business Strategy:

Leading players in the global topical hemostat market, including Baxter International Inc., Johnson & Johnson, B. Braun Melsungen AG, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to strengthen their market presence. These companies invest in R&D to develop advanced hemostatic solutions, including fibrin sealants, bioabsorbable agents, and combination hemostatic technologies catering to diverse surgical needs. Collaborations with hospitals, surgical centers, and distributors facilitate market expansion and drive product adoption. Additionally, companies emphasize clinical research and physician education to enhance market acceptance and improve surgical outcomes.

Key Companies Profiled:

  • Baxter International Inc.
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Medtronic plc
  • Pfizer Inc.
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • CryoLife, Inc.
  • Biom'Up SAS

Topical Hemostat Market Segmentation

By Type

  • Fibrin
  • Thrombin
  • Cellulose
  • Collagen
  • Gelatin
  • Adhesives

By Application

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery

By End Use

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Topical Hemostat Market Snapshot 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global Textile Typeion by Region
    • 2.3.3. Global Cloths Demand by Region
    • 2.3.4. Global Knitting Machine Sales Overview
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Topical Hemostat Market Outlook:

  • 5.1. Key Highlights
  • 5.2. Global Topical Hemostat Market Outlook: Type
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Type, 2019-2024
    • 5.2.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
      • 5.2.3.1. Fibrin
      • 5.2.3.2. Thrombin
      • 5.2.3.3. Cellulose
      • 5.2.3.4. Collagen
      • 5.2.3.5. Gelatin
      • 5.2.3.6. Adhesives
    • 5.2.4. Market Attractiveness Analysis: Type
  • 5.3. Global Topical Hemostat Market Outlook: Application
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Application, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
      • 5.3.3.1. General Surgery
      • 5.3.3.2. Neurosurgery
      • 5.3.3.3. Vascular Surgery
      • 5.3.3.4. Cardiovascular Surgery
    • 5.3.4. Market Attractiveness Analysis: Application
  • 5.4. Global Topical Hemostat Market Outlook: End Use
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by End Use, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Ambulatory Surgical Centers

6. Global Topical Hemostat Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Topical Hemostat Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 7.4.1. Fibrin
    • 7.4.2. Thrombin
    • 7.4.3. Cellulose
    • 7.4.4. Collagen
    • 7.4.5. Gelatin
    • 7.4.6. Adhesives
  • 7.5. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 7.5.1. General Surgery
    • 7.5.2. Neurosurgery
    • 7.5.3. Vascular Surgery
    • 7.5.4. Cardiovascular Surgery
  • 7.6. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Surgical Centers

8. Europe Topical Hemostat Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 8.4.1. Fibrin
    • 8.4.2. Thrombin
    • 8.4.3. Cellulose
    • 8.4.4. Collagen
    • 8.4.5. Gelatin
    • 8.4.6. Adhesives
  • 8.5. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 8.5.1. General Surgery
    • 8.5.2. Neurosurgery
    • 8.5.3. Vascular Surgery
    • 8.5.4. Cardiovascular Surgery
  • 8.6. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Surgical Centers

9. East Asia Topical Hemostat Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 9.4.1. Fibrin
    • 9.4.2. Thrombin
    • 9.4.3. Cellulose
    • 9.4.4. Collagen
    • 9.4.5. Gelatin
    • 9.4.6. Adhesives
  • 9.5. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 9.5.1. General Surgery
    • 9.5.2. Neurosurgery
    • 9.5.3. Vascular Surgery
    • 9.5.4. Cardiovascular Surgery
  • 9.6. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers

10. South Asia & Oceania Topical Hemostat Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 10.4.1. Fibrin
    • 10.4.2. Thrombin
    • 10.4.3. Cellulose
    • 10.4.4. Collagen
    • 10.4.5. Gelatin
    • 10.4.6. Adhesives
  • 10.5. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 10.5.1. General Surgery
    • 10.5.2. Neurosurgery
    • 10.5.3. Vascular Surgery
    • 10.5.4. Cardiovascular Surgery
  • 10.6. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Surgical Centers

11. Latin America Topical Hemostat Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 11.4.1. Fibrin
    • 11.4.2. Thrombin
    • 11.4.3. Cellulose
    • 11.4.4. Collagen
    • 11.4.5. Gelatin
    • 11.4.6. Adhesives
  • 11.5. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 11.5.1. General Surgery
    • 11.5.2. Neurosurgery
    • 11.5.3. Vascular Surgery
    • 11.5.4. Cardiovascular Surgery
  • 11.6. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Surgical Centers

12. Middle East & Africa Topical Hemostat Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 12.4.1. Fibrin
    • 12.4.2. Thrombin
    • 12.4.3. Cellulose
    • 12.4.4. Collagen
    • 12.4.5. Gelatin
    • 12.4.6. Adhesives
  • 12.5. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 12.5.1. General Surgery
    • 12.5.2. Neurosurgery
    • 12.5.3. Vascular Surgery
    • 12.5.4. Cardiovascular Surgery
  • 12.6. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Surgical Centers

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. BD
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Type Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Baxter
    • 13.3.3. Pfizer Inc.
    • 13.3.4. Medicom
    • 13.3.5. HemoSonics
    • 13.3.6. Hemostasis, LLC
    • 13.3.7. Medline Industries
    • 13.3.8. Johnson & Johnson
    • 13.3.9. Integra LifeSciences
    • 13.3.10. Teleflex Incorporated
    • 13.3.11. HemCon Medical Technologies Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations